A PHASE-II MULTICENTER STUDY OF SEQUENTIAL, RESPONSE-ADAPTED INDUCTION REGIMENS IDARUBICIN CYTARABINE AND MITOXANTRONE ETOPOSIDE, FOR TREATMENT OF DE-NOVO AML
R. Vanderjagt et al., A PHASE-II MULTICENTER STUDY OF SEQUENTIAL, RESPONSE-ADAPTED INDUCTION REGIMENS IDARUBICIN CYTARABINE AND MITOXANTRONE ETOPOSIDE, FOR TREATMENT OF DE-NOVO AML, Blood, 84(10), 1994, pp. 10000304-10000304